SCHEMBL31489650

SCHEMBL31489650

CCC(c1ccc(F)cc1)n1cc(-c2cccc(-c3ccn4nc(N)nc4c3)c2F)cn1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.37
PIK3CG P48736 12/20 0.36
PIK3CD O00329 10/20 0.36
CYP17A1 P05093 1/20 0.34
JAK1 P23458 2/20 0.33
PAK4 O96013 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
CSNK1A1 P48729 1/20 0.33
AAK1 Q2M2I8 1/20 0.33
PIP4K2C Q8TBX8 1/20 0.33
CSNK1G1 Q9HCP0 1/20 0.33
JAK2 O60674 1/20 0.31
TYK2 P29597 1/20 0.31
JAK3 P52333 1/20 0.31
NTRK1 P04629 1/20 0.31
TNIK Q9UKE5 1/20 0.31
ROCK2 O75116 1/20 0.31
TDP2 O95551 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489908 1.00 RIPK1 (0.37) RIPK1PIK3CGPIK3CDCYP17A1JAK1
SCHEMBL31489759 0.94 RIPK1 (0.38) RIPK1PIK3CGPIK3CDJAK1PAK4
SCHEMBL31489414 0.94 RIPK1 (0.38) RIPK1PIK3CGPIK3CDJAK1PAK4
SCHEMBL31489633 0.88 RIPK1 (0.40) RIPK1PIK3CGPIK3CDJAK1PAK4
SCHEMBL31489701 0.88 RIPK1 (0.40) RIPK1PIK3CGPIK3CDJAK1PAK4
SCHEMBL31489761 0.87 JAK2 (0.33) PIK3CGPIK3CDCYP17A1JAK1PIK3CA
SCHEMBL31489367 0.86 PIK3CG (0.37) RIPK1PIK3CGPIK3CDCYP17A1JAK1
SCHEMBL31489786 0.86 PIK3CG (0.37) RIPK1PIK3CGPIK3CDCYP17A1JAK1
SCHEMBL31489337 0.86 JAK2 (0.32) PIK3CGPIK3CDCYP17A1JAK1PIK3CA
SCHEMBL31489876 0.85 PIK3CG (0.39) RIPK1PIK3CGPIK3CDCYP17A1JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed